Photo from wikipedia
Current interest in HCV therapy with direct acting antivirals is focused on shortening treatment length. We managed two cirrhotics who achieved virological cure after 4 weeks of ombitasvir/paritaprevir/ritonavir, dasabuvir, ribavirin… Click to show full abstract
Current interest in HCV therapy with direct acting antivirals is focused on shortening treatment length. We managed two cirrhotics who achieved virological cure after 4 weeks of ombitasvir/paritaprevir/ritonavir, dasabuvir, ribavirin treatment. Analysis to identify potential predictive factors for a successful outcome with a shorter treatment course was conducted.
Keywords:
shorter treatment;
treatment;
course chronic;
treatment course;
chronic hepatitis
Journal Title: Journal of Chemotherapy
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Chemotherapy
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!